The work of the successful postdoc, Michelle Geryk, will be focused on studying the cardiomyocytes differentiated from patients harbouring cardiac mutations resulting in arrhythmia and/or cardiomyopathy. Genotype-phenotype relationships shall be studied to decipher mechanism of disease onset and progression as well as novel therapeutic targets and interactions of drugs already in clinical settings. The responsibility of Michelle Geryk will include analyzing and interpreting data from multiple assays, structural biology, mechanobiology, genomics, proteomics data, and data on drug toxicity. She will develop research protocols and carry out experiments. Data collected shall be analyzed in a complex manner.